Journal Publications

Export 124 results:
Author Title [ Type(Desc)] Year
Filters: Type is Journal Article  [Clear All Filters]
Journal Article
Is 1 alanine transaminase >200 IU enough to define an alanine transaminase flare in HIV-infected populations? A new definition derived from a large cohort study. Bansi L, Turner J, Gilson R, Post F, Gazzard B, Leen C, Anderson J, Porter K, Hill T, Fisher M et al. J Acquir Immune Defic Syndr, 2009 Nov 01, Volume 52, Issue 3, p.391-6, (2009)
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth J, van Sighem A, Kirk O, Obel N, Panos G et al. Int J Epidemiol, 2012 Apr, Volume 41, Issue 2, p.433-45, (2012)
Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia. Mackie N, Phillips A, Kaye S, Booth C and Geretti A. J Infect Dis, 2010 May 01, Volume 201, Issue 9, p.1303-7, (2010)
Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease. Garvey L, Winston A, Walsh J, Post F, Porter K, Gazzard B, Fisher M, Leen C, Pillay D, Hill T et al. Neurology, 2011 Feb 22, Volume 76, Issue 8, p.693-700, (2011)
Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression? Bansi L, Benzie A, Phillips A, Portsmouth S, Hill T, Leen C, Schwenk A, Johnson M, Anderson J, Gilson R et al. AIDS, 2008 Jan 30, Volume 22, Issue 3, p.349-56, (2008)
Association between engagement in-care and mortality in HIV-positive persons. Sabin C, Howarth A, Jose S, Hill T, Apea V, Morris S and Burns F. AIDS, 2017 Mar 13, Volume 31, Issue 5, p.653-660, (2017)
The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy. Sabin C, Smith C, Delpech V, Anderson J, Bansi L, Gilson R, Schwenk A, Leen C, Gazzard B, Porter K et al. HIV Med, 2009 Jan, Volume 10, Issue 1, p.35-43, (2009)
Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients. Ibrahim F, Hamzah L, Jones R, Nitsch D, Sabin C and Post F. Am J Kidney Dis, 2012 Oct, Volume 60, Issue 4, p.539-47, (2012)
Biomarkers to monitor safety in people on art and risk of mortality. Bansi L, Gazzard B, Post F, Phillips A, Johnson M, Hill T, Gilson R, Leen C, Walsh J, Fisher M et al. J Acquir Immune Defic Syndr, 2012 May 01, Volume 60, Issue 1, p.51-8, (2012)
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe. Nakagawa F, Lodwick R, Costagliola D, van Sighem A, Torti C, Podzamczer D, Mocroft A, Ledergerber B, Dorrucci M, Cozzi-Lepri A et al. J Acquir Immune Defic Syndr, 2012 Mar 01, Volume 59, Issue 3, p.294-9, (2012)
Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights. Martin N, Thornton A, Hickman M, Sabin C, Nelson M, Cooke G, Martin T, Delpech V, Ruf M, Price H et al. Clin Infect Dis, 2016 May 01, Volume 62, Issue 9, p.1072-1080, (2016)
Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-score. Cozzi-Lepri A, Prosperi M, Kjær J, Dunn D, Paredes R, Sabin C, Lundgren J, Phillips A and Pillay D. PLoS One, 2011, Volume 6, Issue 11, p.e25665, (2011)
CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003. Stöhr W, Dunn D, Porter K, Hill T, Gazzard B, Walsh J, Gilson R, Easterbrook P, Fisher M, Johnson M et al. HIV Med, 2007 Apr, Volume 8, Issue 3, p.135-41, (2007)
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutiérrez F et al. PLoS Med, 2012, Volume 9, Issue 3, p.e1001194, (2012)
CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK. Bower M, Fisher M, Hill T, Reeves I, Walsh J, Orkin C, Phillips A, Bansi L, Gilson R, Easterbrook P et al. Haematologica, 2009 Jun, Volume 94, Issue 6, p.875-80, (2009)
Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3. Porter K, Walker S, Hill T, Anderson J, Leen C, Johnson M, Gazzard B, Walsh J, Fisher M, Orkin C et al. J Acquir Immune Defic Syndr, 2008 Feb 01, Volume 47, Issue 2, p.202-5, (2008)
Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study. Wang Q, De Luca A, Smith C, Zangerle R, Sambatakou H, Bonnet F, Smit C, Schommers P, Thornton A, Berenguer J et al. Ann Intern Med, 2017 01 03, Volume 166, Issue 1, p.9-17, (2017)
Chronic kidney disease risk in African and Caribbean populations with HIV. Jose S, Hamzah L, Jones R, Williams D, Winston A, Burns F, Phillips A, Sabin C and UK CHIC Study. J Inf Dis, (2018)
Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort study. Warren-Gash C, Childs K, Thornton A, Bhagani S, Demma S, Srivastava A, Leen C, Agarwal K, Rodger A and Sabin C. Infection, 2017 Apr, Volume 45, Issue 2, p.215-220, (2017)
Clinical characteristics and outcomes of HIV-associated immune complex kidney disease. Booth J, Hamzah L, Jose S, Horsfield C, O'Donnell P, McAdoo S, Kumar E, Turner-Stokes T, Khatib N, Das P et al. Nephrol Dial Transplant, 2016 Dec, Volume 31, Issue 12, p.2099-2107, (2016)
Clinical epidemiology of HIV-associated end-stage renal failure in the UK. Bansi L, Hughes A, Bhagani S, Mackie N, Leen C, Levy J, Edwards S, Connolly J, Holt S, Hendry B et al. AIDS, 2009 Nov 27, Volume 23, Issue 18, p.2517-21, (2009)
Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients. Ibrahim F, Hamzah L, Jones R, Nitsch D, Sabin C and Post F. Nephrol Dial Transplant, 2012 Jun, Volume 27, Issue 6, p.2291-7, (2012)
A continuum of HIV care describing mortality and loss to follow-up; a longitudinal cohort study. Jose S, Delpech V, Howarth A, Burns F, Hill T, Porter K, Sabin C and UK CHIC Study Steering Committee. Lancet HIV, (2018)
The contribution of viral genotype to plasma viral set-point in HIV infection. Hodcroft E, Hadfield J, Fearnhill E, Phillips A, Dunn D, O'Shea S, Pillay D and Brown A. PLoS Pathog, 2014 May, Volume 10, Issue 5, p.e1004112, (2014)
The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study. . HIV Med, 2004 Mar, Volume 5, Issue 2, p.115-24, (2004)